Deleterious versus beneficial effects of prostacyclin in patients with coronary artery disease: hemodynamic rationale.
D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D004341:Drug Evaluation; D011464:Epoprostenol / Q000009:adverse effects / Q000627:therapeutic use*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans
D011464:Epoprostenol